glp‑1 weight‑loss drugs
Halve Claims with Prescription Weight‑Loss Coverage
70% of midsize companies can pinpoint employees at elevated obesity risk, a figure that drives a potential 12% cut in medical costs over three years. By embedding GLP-1 prescription pathways into benefits, HR leaders can turn that insight into measurable health savings and productivity gains. This approach balances clinical efficacy